Duncan Whitney promoted to senior VP at Allegro
This article was originally published in Scrip
Allegro Diagnostics, a molecular diagnostics company developing innovative genomic tests for the diagnosis, staging and informed treatment of lung cancer and other lung diseases, has appointed Dr Duncan Whitney senior vice-president of research and development. Dr Whitney joined Allegro in January 2010 having previously served as chief scientific officer of Progenika, a microarray-based clinical diagnostics company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.